microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sunantha SethuramanLauren Appleby GayVaibhav JainIrina HäckerRolf RennePublished in: PLoS pathogens (2017)
Kaposi's sarcoma (KS) is a highly prevalent cancer in AIDS patients, especially in sub-Saharan Africa. Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of KS and other cancers like Primary Effusion Lymphoma (PEL). In KS and PEL, all tumors harbor latent KSHV episomes and express latency-associated viral proteins and microRNAs (miRNAs). The exact molecular mechanisms by which latent KSHV drives tumorigenesis are not completely understood. Recent developments have highlighted the importance of aberrant long non-coding RNA (lncRNA) expression in cancer. Deregulation of lncRNAs by miRNAs is a newly described phenomenon. We hypothesized that KSHV-encoded miRNAs deregulate human lncRNAs to drive tumorigenesis. We performed lncRNA expression profiling of endothelial cells infected with wt and miRNA-deleted KSHV and identified 126 lncRNAs as putative viral miRNA targets. Here we show that KSHV deregulates host lncRNAs in both a miRNA-dependent fashion by direct interaction and in a miRNA-independent fashion through latency-associated proteins. Several lncRNAs that were previously implicated in cancer, including MEG3, ANRIL and UCA1, are deregulated by KSHV. Our results also demonstrate that KSHV-mediated UCA1 deregulation contributes to increased proliferation and migration of endothelial cells.
Keyphrases
- long non coding rna
- poor prognosis
- endothelial cells
- papillary thyroid
- squamous cell
- genome wide identification
- sars cov
- network analysis
- newly diagnosed
- genome wide analysis
- ejection fraction
- high glucose
- diffuse large b cell lymphoma
- childhood cancer
- transcription factor
- gene expression
- long noncoding rna
- patient reported